Serum endocan levels as a marker of disease activity in patients with Behçet disease.

[1]  C. Ergin,et al.  Mean Platelet Volume in Recurrent Aphthous Stomatitis and Behçet Disease , 2014, Angiology.

[2]  D. Mikhailidis,et al.  Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease , 2013, The British journal of dermatology.

[3]  M. Delehedde,et al.  Endocan in Cancers: A Lesson from a Circulating Dermatan Sulfate Proteoglycan , 2013, International journal of cell biology.

[4]  W. Wei,et al.  Expression and distribution of endocan in human tissues , 2012, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[5]  A. Dogan,et al.  Effects of Atorvastatin and Lisinopril on Endothelial Dysfunction in Patients with Behçet's Disease , 2010, Echocardiography.

[6]  Jay W. Shin,et al.  Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. , 2008, Blood.

[7]  S. Oktar,et al.  Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet’s disease , 2008, Clinical Rheumatology.

[8]  J. Komorowski,et al.  Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. , 2007, Experimental cell research.

[9]  E. Yıldırım,et al.  Endothelial functions are more severely impaired during active disease period in patients with Behcet’s disease , 2007, Clinical Rheumatology.

[10]  W. Aird,et al.  Vascular endocan is preferentially expressed in tumor endothelium. , 2006, Microvascular research.

[11]  J. Pugin,et al.  Endocan, a new endothelial marker in human sepsis* , 2006, Critical care medicine.

[12]  M. Lyon,et al.  Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. , 2006, Biochimica et biophysica acta.

[13]  Y. Turkoz,et al.  Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome , 2003, International journal of dermatology.

[14]  B. Jude,et al.  Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic Activity* , 2001, The Journal of Biological Chemistry.

[15]  H. Hammad,et al.  Human Endothelial-Cell Specific Molecule-1 Binds Directly to the Integrin CD11a/CD18 (LFA-1) and Blocks Binding to Intercellular Adhesion Molecule-11 , 2001, The Journal of Immunology.

[16]  V. Meignin,et al.  Characterization of the Secreted Form of Endothelial-Cell-Specific Molecule 1 by Specific Monoclonal Antibodies , 2000, Journal of Vascular Research.

[17]  Ş. Kirazlı,et al.  Selectin adhesion molecules in Behçet's disease , 2000, Annals of the rheumatic diseases.

[18]  Y. Kohno,et al.  Vascular endothelial growth factor in acute Kawasaki disease. , 1999, The American journal of cardiology.

[19]  P. Welker,et al.  Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. , 1998, Molecular biology of the cell.

[20]  K. Tanikawa,et al.  Vascular endothelial growth factor in patients with rheumatoid arthritis. , 1998, Scandinavian journal of rheumatology.

[21]  J. Tavernier,et al.  ESM-1 Is a Novel Human Endothelial Cell-specific Molecule Expressed in Lung and Regulated by Cytokines* , 1996, The Journal of Biological Chemistry.

[22]  International Study Group for Behçet's Disease,et al.  Criteria for diagnosis of Behcet's disease , 1990, The Lancet.

[23]  E. Stolz,et al.  [Behçet's disease]. , 1987, Nederlands tijdschrift voor geneeskunde.

[24]  H. Behcet.  UBER REZIDIVERENDE APHTHOSE DURCH EIN VIRUS VERURSACHTE GESCHWURE AM MUND, AM AUGE UND AN DEN GENITALIEN , 1937 .